Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-394-3 | CAS number: 1782069-81-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 3 March 1986 to 25 April 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1983
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Version / remarks:
- 1982
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell transformation assay
Test material
- Reference substance name:
- (3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
- EC Number:
- 701-394-3
- Cas Number:
- 1782069-81-1
- Molecular formula:
- C18H22O
- IUPAC Name:
- (3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Constituent 1
Method
- Target gene:
- Chinese hamster cell line V79
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: Laboratory stock
- Suitability of cells: The V79 cell line has been used for many years in in vitro experiments with success. The high proliferation rate and plating efficiency of untreated cells are necessary for the appropriate performance of the study.
- Cell cycle length, doubling time or proliferation index: Doubling time 12 to 16 hours in stock cultures.
- Methods for maintenance in cell culture: Thawed stock cultures were propagated at 37°C in plastic flasks. Seeding was done with 100000 to 300000 cells per flask in 5 mL of MEM-medium supplemented with 10% fetal calf serum. Cells were subcultured twice a week.
- Modal number of chromosomes: 22
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9
- Test concentrations with justification for top dose:
- The highest concentration should reduce the mitotic index to about 50 % as compared to the solvent control.
7 hour preparation time: 10 μg/mL (without S9) and 36 μg/mL (with S9)
18 hour preparation time: 1, 5 and 11 μg/mL (without S9) and 3, 15 and 36 μg/mL (with S9)
28 hour preparation time: 11 μg/mL (without S9) and 36 μg/mL (with S9) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol (1%)
- Justification for choice of solvent/vehicle: Ethanol is relatively non-toxic in the concentrations applied.
Controls
- Untreated negative controls:
- yes
- Remarks:
- untreated cultures
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: ethyl methanesulfonate (without metabolic activation), cyclophosphamide (with metabolic activation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in suspension
- Cell density at seeding: Two days old logarithmically growing stock cultures more than 50% confluent were trypsinised and a single cell suspension was prepared. The cells were seeded into four parallel plastic tissue culture flasks at a concentration of 300000 cells per flask (7 hour interval) and 150000 cells per flask (18 and 28 hour intervals).
DURATION
- Preincubation period: 48 hours
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 5, 15.5 and 25.5 hours after the start of treatment
- Fixation time: 2.0 (7 hour interval) or 2.5 (18 and 28 hour intervals) hours from addition of colcemid
STAIN: Aceto-orcein
NUMBER OF REPLICATIONS: 4
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: Cells were trypsinised and suspended in a hypotonic solution (37.5 mM KCl) for 10 minutes at 37°C. After centrifugation (800 to 1000 rpm) the cell pellets were fixed in three steps with glacial acetic acid/ methanol 1 + 3 and stored overnight at 4°C. The next day the cells were spread on wet and ice cold slides and stained.
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE: 100 metaphases/flask were scored per test concentration.
DETERMINATION OF CYTOTOXICITY
- Method: Mitotic index
- Any supplementary information relevant to cytotoxicity: Mitotic index was determined in 1000 cells in each replicate. - Rationale for test conditions:
- The test item concentrations were determined in a preliminary experiment using the mitotic index and plating efficiencies as an indicator for toxicity response.
- Evaluation criteria:
- Gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations were recorded as structural aberrations.
1. The test substance is classified as mutagenic if it induces with one of the concentrations tested a significantly increased aberration rate as compared with the negative control. The significance is obvious either by an enhancement of the rate clearly over the control range or it is proven by adequate biometry.
2. The test substance is classified as mutagenic if there is a concentration related increase in the aberration rates as compared with the solvent controls.
3. The test substance is considered negative when 1 and 2 do not apply. - Statistics:
- No statistical analysis performed as there is no indication of a dose-response relationship.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES: See Table 2.
The sensitivity of the test system was demonstrated by the clearly enhanced structural aberration rates found in the groups treated with the positive control substances.
In only one group of cells treated with the lowest concentration of the test item, a higher number of cells with structural chromosome aberrations as compared to the range of the negative controls was found in the presence of S9 mix at preparation interval 18 h. In all other groups treated with the test item, aberration rates within or near the control range were found. This single higher value alone is not regarded as being sufficient to prove mutagenicity.
Any other information on results incl. tables
Table 1. Mutagenicity data and mitotic index
Preparation time | Treatment group | Total cells analysed | Number of aberrant cells including gaps | % of aberrant cells including gaps | Number of aberrant cells excluding gaps | % of aberrant cells excluding gaps | % of aberrant cell exchanges | % mitotic index (absolute) | % mitotic index (relative) |
18 hours | Untreated control -S9 | 400 | 9 | 2.25 | 5 | 1.25 | 0.25 | 6.8 | 100.0 |
18 hours | Untreated control +S9 | 400 | 24 | 6.00 | 7 | 1.75 | 0.00 | 6.0 | 100.0 |
18 hours | Solvent control -S9 | 400 | 17 | 4.25 | 4 | 1.00 | 0.00 | 4.8 | 100.0 |
18 hours | Solvent control +S9 | 400 | 14 | 3.50 | 9 | 2.25 | 0.25 | 5.4 | 100.0 |
18 hours | Positive control -S9 | 200 | 60 | 60.00 | 52 | 52.00 | 45.00 | 7.7 | 113.2 |
18 hours | Positive control +S9 | 200 | 69 | 69.00 | 65 | 65.00 | 39.00 | 4.3 | 71.6 |
18 hours | 1 μg/mL test item -S9 | 400 | 23 | 5.75 | 10 | 2.50 | 0.00 | 4.6 | 95.6 |
18 hours | 3 μg/mL test item +S9 | 400 | 37 | 9.25 | 19 | 4.75 | 0.00 | 4.5 | 83.6 |
18 hours | 5 μg/mL test item -S9 | 400 | 19 | 4.75 | 5 | 1.25 | 0.25 | 5.6 | 115.6 |
18 hours | 15 μg/mL test item +S9 | 400 | 13 | 3.25 | 4 | 1.00 | 0.50 | 2.9 | 54.2 |
18 hours | 11 μg/mL test item -S9 | 400 | 17 | 4.25 | 11 | 2.75 | 0.50 | 3.2 | 65.8 |
18 hours | 36 μg/mL test item +S9 | 400 | 21 | 5.25 | 5 | 1.25 | 0.00 | 7.5 | 139.8 |
7 hours | Solvent control -S9 | 400 | 16 | 4.00 | 4 | 1.00 | 0.00 | 5.9 | 100.0 |
7 hours | Solvent control +S9 | 400 | 10 | 2.50 | 1 | 0.25 | 0.00 | 5.9 | 100.0 |
7 hours | 10 μg/mL test item -S9 | 400 | 14 | 3.50 | 8 | 2.00 | 0.00 | 2.8 | 47.7 |
7 hours | 36 μg/mL test item +S9 | 400 | 28 | 7.00 | 13 | 3.25 | 0.00 | 5.2 | 86.9 |
28 hours | Solvent control -S9 | 400 | 17 | 4.25 | 6 |
1.50 | 0.25 | 4.4 | 100.0 |
28 hours | Solvent control +S9 | 400 | 10 | 2.50 | 2 | 0.50 | 0.00 | 1.9 | 43.1 |
28 hours | 11 μg/mL test item -S9 | 400 | 11 | 2.75 | 6 | 1.50 | 0.5 | 5.7 | 100.0 |
28 hours | 36 μg/mL test item +S9 | 400 | 25 | 6.25 | 10 | 2.50 | 0.00 | 5.7 | 99.1 |
Table 2. Preliminary study results
Treatment group | Number of seeded cells per flask | Mean number of found cells per flask | % PE (absolute) | % PE (relative) |
Untreated control -S9 | 496 | 300.0 | 60.5 | 100.0 |
Untreated control +S9 | 498 | 435.0 | 87.3 | 100.0 |
Solvent control -S9 | 496 | 311.5 | 62.8 | 100.0 |
Solvent control +S9 | 498 | 387.0 | 77.7 | 100.0 |
10.0 μg/mL test item -S9 | 496 | 224.0 | 45.2 | 71.9 |
11.0 μg/mL test item -S9 | 496 | 155.5 | 31.4 | 49.9 |
12.0 μg/mL test item -S9 | 496 | 20.0 | 4.0 | 6.4 |
13.0 μg/mL test item -S9 | 496 | 17.0 | 3.4 | 5.5 |
14.0 μg/mL test item -S9 | 496 | 0.0 | 0.0 | 0.0 |
15.0 μg/mL test item -S9 | 496 | 0.0 | 0.0 | 0.0 |
15.0 μg/mL test item +S9 | 498 | 356.5 | 71.6 | 92.1 |
20.0 μg/mL test item +S9 | 498 | 377.5 | 75.8 | 97.5 |
25.0 μg/mL test item +S9 | 498 | 350.5 | 70.4 | 90.6 |
30.0 μg/mL test item +S9 | 498 | 342.0 | 68.7 | 88.4 |
35.0 μg/mL test item +S9 | 498 | 233.5 | 46.9 | 60.3 |
40.0 μg/mL test item +S9 | 498 | 2.0 | 0.4 | 0.5 |
Applicant's summary and conclusion
- Conclusions:
- The test item was not mutagenic to V79 Chinese hamster cell line in vitro in the presence and absence of metabolic activation.
- Executive summary:
The potential of the test item to induce chromosomal aberrations was determined in vitro with cells of the V79 Chinese hamster cell line according to OECD Guideline 473. Chinese hamster lung fibroblasts V79 were treated with the test item at concentrations of 1, 5, 10 and 11 µg/mL without S9-activation and 3, 15 and 36 µg/mL with S9-activation. Cells were incubated with the test item for 4 hours, followed by a 5, 15.5 or 25.5 -hour incubation period in growth medium. Colcemid was added as a fixing agent and the cells were incubated for a further 2.0 or 2.5 hours. The study included negative, solvent and positive (ethyl methanesulfonate and cyclophosphamide) controls . Mutagenicity was evaluated by determining the number of gaps, breaks, fragments, deletions, exchanges and chromosomal disintegrations in 400 metaphases per test concentration. Cytotoxicity was evaluated by determination of mitotic index in 1000 cells in each replicate. The test item was not mutagenic to V79 Chinese hamster cell line in the presence and absence of metabolic activation. This study is considered reliable without restriction (Klimisch 1).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.